Cited 2 time in
Characteristics of Gastric Carcinomas With High ERCC1 Expression and the Prognostic Value of ERCC1 Expression
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yang, Jung Wook | - |
| dc.contributor.author | Lee, Jeong-Hee | - |
| dc.contributor.author | Lee, Jong Sil | - |
| dc.contributor.author | Kim, Dong Chul | - |
| dc.contributor.author | Song, Dae Hyun | - |
| dc.contributor.author | Jang, Se Min | - |
| dc.contributor.author | An, Hyo Jung | - |
| dc.contributor.author | Koh, Hyun Min | - |
| dc.contributor.author | Kim, Minhye | - |
| dc.contributor.author | Na, Ji Min | - |
| dc.contributor.author | Jeong, Sang-Ho | - |
| dc.contributor.author | Lee, Young-Joon | - |
| dc.contributor.author | Ko, Gyung Hyuck | - |
| dc.date.accessioned | 2022-12-26T12:46:53Z | - |
| dc.date.available | 2022-12-26T12:46:53Z | - |
| dc.date.issued | 2020-06 | - |
| dc.identifier.issn | 0250-7005 | - |
| dc.identifier.issn | 1791-7530 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/6587 | - |
| dc.description.abstract | Background/Aim: We aimed to evaluate the characteristics of gastric carcinoma with high excision repair cross complementing 1 (ERCC1) expression and the prognostic value of ERCC1 expression. Materials and Methods: ERCC1 expression was evaluated by immunohistochemistry in 309 surgically resected gastric carcinoma specimens using a tissue microarray. Cancer-related survival was analysed using competing risk analysis. Results: Compared to ERCC1-low gastric carcinomas, ERCC1-high gastric carcinomas showed less local invasion (p=0.0013), lower N stage (p=0.0302), earlier pTNM stage (p=0.0003), and less frequent recurrence (p=0002). Patients with ERCC1-high gastric carcinoma showed lower cumulative incidence function estimate of cancer-related death [3.37; 95% confidence intervaI (CI)=0.89-8.75] than did those with ERCC1-low gastric carcinoma (17.12; 95% CI=12.24-22.69; p-value by Gray's test=0.0012). Adjusted proportional sub-distribution hazard ratio for cancer- related death in the patients with ERCC1-high tumour was 0.272 (95% CI=0.084-0.878; p=0.0295). Conclusion: High ERCC1 expression may be an independent positive prognostic marker for gastric carcinoma. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | International Institute of Anticancer Research | - |
| dc.title | Characteristics of Gastric Carcinomas With High ERCC1 Expression and the Prognostic Value of ERCC1 Expression | - |
| dc.type | Article | - |
| dc.publisher.location | 그리이스 | - |
| dc.identifier.doi | 10.21873/anticanres.14301 | - |
| dc.identifier.scopusid | 2-s2.0-85085854247 | - |
| dc.identifier.wosid | 000538104800020 | - |
| dc.identifier.bibliographicCitation | Anticancer Research, v.40, no.6, pp 3203 - 3208 | - |
| dc.citation.title | Anticancer Research | - |
| dc.citation.volume | 40 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 3203 | - |
| dc.citation.endPage | 3208 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | PLATINUM-BASED CHEMOTHERAPY | - |
| dc.subject.keywordPlus | CELL LUNG-CANCER | - |
| dc.subject.keywordPlus | EXCISION-REPAIR | - |
| dc.subject.keywordPlus | CISPLATIN | - |
| dc.subject.keywordPlus | RESISTANCE | - |
| dc.subject.keywordAuthor | Stomach | - |
| dc.subject.keywordAuthor | cisplatin | - |
| dc.subject.keywordAuthor | ERCC1 | - |
| dc.subject.keywordAuthor | human gastric carcinoma | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0534
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
